Position in INSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$109,084,412
-$136,568,574 QoQ
Shares Held
1,023,114
-31.9% QoQ
Ownership
0.468%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#42
of 665 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 42%
Shared 0%
None 58%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Derivatives in INSM
reported options exposure · as of Sep 30, 2025CallValue
$27,693,123
CallShares
192,300
PutValue
$32,013,423
PutShares
222,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. INSM ranks #22 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in INSM
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $109,084,412 | 1,023,114 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $245,652,986 | 1,502,281 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $300,337,517 | 1,725,681 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $230,676,079 | 1,601,806 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $32,013,423 | 222,300 | Put | Defined | 2026-02-03 | |
| 2025-09-30 | $27,693,123 | 192,300 | Call | Defined | 2026-02-03 | |
| 2025-06-30 | $123,458,809 | 1,226,737 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $1,237,872 | 12,300 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $1,237,872 | 12,300 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $103,220,291 | 1,352,999 | Shares | Defined | 2025-05-15 | |
| 2025-03-31 | $2,059,830 | 27,000 | Call | Defined | 2025-05-15 | |
| 2024-12-31 | $76,473,257 | 1,107,666 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $84,234,554 | 1,153,898 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $74,986,936 | 1,119,208 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $27,024,949 | 996,128 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $32,348,319 | 1,043,831 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $30,527,904 | 1,209,026 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $17,766,451 | 842,012 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $16,784,357 | 984,420 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $13,715,488 | 686,461 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $12,748,597 | 591,857 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $10,689,261 | 542,052 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $13,867,771 | 590,118 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $11,720,632 | 430,273 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $10,460,102 | 379,815 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $10,470,402 | 367,899 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $7,379,470 | 216,661 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $4,662,528 | 140,058 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $8,406,824 | 261,569 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $4,757,835 | 172,761 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,043,453 | 127,477 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||